SIGA Investor Relations Material

SIGA Technologies, Inc. is a pharmaceutical company focused on the development and commercialization of countermeasures to address infectious diseases and biological threats. The company specializes in antiviral therapies, with a particular emphasis on treatments for diseases caused by orthopoxviruses, including smallpox. SIGA’s products are primarily used by government agencies and health organizations to strengthen preparedness for potential outbreaks or bioterrorism events. The company is headquartered in New York, New York, and its shares are listed on the NASDAQ.